I-Te Chen

Papers

Total Citations

H-Index

About

Dr. I-Te Chen is a surgical outcomes researcher whose work centers on quality-of-life (QOL) assessment and comparative effectiveness in hepatocellular carcinoma (HCC) treatment. His most cited study, a 2022 prospective longitudinal cohort analysis of 520 HCC patients, employed inverse probability of treatment weighting to compare QOL trajectories across three surgical procedures. This work demonstrated that long-term changes in individual QOL subscales are not uniform, and identified key predictors of post-surgical well-being. With 6 citations, this paper has provided critical methodological guidance for using causal inference techniques in surgical QOL research. Dr. Chen’s contributions lie in advancing patient-centered outcomes measurement and demonstrating how rigorous statistical methods can reveal meaningful differences in recovery experiences. His research bridges the gap between surgical efficacy and patient-reported quality of life, offering actionable insights for preoperative counseling and postoperative care. By focusing on the nuanced, longitudinal nature of recovery, Dr. Chen’s work helps clinicians and patients make more informed treatment decisions, ultimately improving long-term survivorship experiences in HCC patients.